Markets By TradingView

Worth buying in October 2 Robinhood Dividend Stocks: Bank of America & Pfizer

Worth buying in October 2 Robinhood Dividend Stocks: Bank of America & Pfizer Worth buying in October 2 Robinhood Dividend Stocks: Bank of America & Pfizer

Worth buying in October 2 Robinhood Dividend Stocks: Bank of America & Pfizer
Yazar: Ross Sutton

Yayınlanma: 8 Ekim 2021 15:23

Güncellenme: 23 Kasım 2024 22:18

Worth buying in October 2 Robinhood Dividend Stocks:

Bank of America & Pfizer

  Worth buying in October 2 Robinhood Dividend Stocks: Bank of America & Pfizer   The reason why Robinhood investors love these dividend stocks is as belongs: The average user of the Robinhood trading platform is not considered to be made keen about dividend stocks. As is known, most of the 100 popular stocks on the Robinhood platform do not pay dividends. But there are always exceptions.

1-Bank of America

Warren Buffett and his longtime business partner, Charlie Munger, aren't exactly Robinhood fans. However, they are undoubtedly big fans of Buffett's favorite bank stock, Bank of America BAC (NYSE) $44,12 -0,12 (-%0,27) Bank of America (27th) is also the favorite and most preferred bank stock for Robinhood investors, the financial services company's dividend yield currently standing at around 2%. Its shares are up more than 40% to date. Patrick Harker, chairman of the Philadelphia Federal Reserve Bank, recently told Reuters that interest rates are on the way. Bank of America investors should enjoy delightful revenue growth when these hikes arrive.  

Worth buying in October 2 Robinhood Dividend Stocks: Bank of America & Pfizer

 

2-Pfizer

Pfizer (NYSE:PFE), the major pharma maker, has been known to be a longtime favorite for revenue investors. Today the dividend yield is over 3.6%. For several years, while Pfizer's dividend was all the company had for it, it's now moved to a very different place, thanks in large part to the phenomenal success of Pfizer's COVID-19 vaccine, Comirnaty. While Comirnaty is Pfizer's biggest growth driver, it is not the only one. The company's roster also includes several blockbusters with a strong momentum, including cancer drugs Inlyta and Xtandi, blood thinners Eliquis, and rare heart disease drug Vyndaqel/Vyndamax. Pfizer is also launching its new pneumococcal conjugate vaccine Prevnar 20, continues to gain value. In addition to all this, Pfizer's pipeline also includes more than 20 programs in late-stage testing, particularly prominent with the respiratory syncytial virus vaccine PF-06928316 and the COVID-19 pill PF-07321332. Worth buying in October 2 Robinhood Dividend Stocks: Bank of America & Pfizer im-410284  

Source: The Motley Fool

 

You may also be interested in:

 

Coca-Cola (KO) Outperforms Stock Market Gains: Points to Know

En Popüler Haberler

Yorum Yap

Yazılan yorumlar hiçbir şekilde Son Ekonomi Haberleri - Türkiye Dünya - ieconomy.io görüş ve düşüncelerini yansıtmamaktadır. Yorumlar, yazan kişiyi bağlayıcı niteliktedir.

Yorumlar

Henüz yorum yapan yok! İlk yorumu siz yapın...

Borsa, Kripto, Hisse, Emtia ve Döviz Haberleri

ieconomy: Türkiye'nin en kapsamlı ekonomi haber sitesi. Son dakika haberleri ve en güncel haberler ieconomy'da.